BlackRock Advisors’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$605K Buy
17,375
+120
+0.7% +$4.71K ﹤0.01% 2100
2016
Q3
$678K Buy
17,255
+1,479
+9% +$59K ﹤0.01% 2020
2016
Q2
$596K Sell
15,776
-56,461
-78% -$1.89M ﹤0.01% 2025
2016
Q1
$2.78M Buy
72,237
+22,993
+47% +$856K ﹤0.01% 1301
2015
Q4
$2.37M Buy
49,244
+3,190
+7% +$148K ﹤0.01% 1346
2015
Q3
$1.82M Sell
46,054
-547
-1% -$23.2K ﹤0.01% 1396
2015
Q2
$1.98M Sell
46,601
-983
-2% -$39.2K ﹤0.01% 1277
2015
Q1
$1.88M Buy
47,584
+5,179
+12% +$191K ﹤0.01% 1258
2014
Q4
$1.53M Sell
42,405
-2,949
-7% -$99.1K ﹤0.01% 1303
2014
Q3
$1.34M Sell
45,354
-479
-1% -$13.2K ﹤0.01% 1307
2014
Q2
$1.15M Sell
45,833
-1,839
-4% -$45.5K ﹤0.01% 1409
2014
Q1
$1.23M Buy
47,672
+21,718
+84% +$547K ﹤0.01% 1403
2013
Q4
$584K Buy
25,954
+7,539
+41% +$146K ﹤0.01% 1921
2013
Q3
$261K Sell
18,415
-1,154
-6% -$15.4K ﹤0.01% 2376
2013
Q2
$267K Buy
+19,569
New +$267K ﹤0.01% 2289

Other funds holding NTUS

BlackRock Advisors's NTUS Position: Q4 2016 in Review

BlackRock Advisors increased its Natus Medical Inc (NTUS) stake by 0.7% in Q4 2016, buying an estimated $4.71K and bringing the position to 17,375 shares worth $605K. The position accounts for ﹤0.01% of the portfolio, ranked #2100.

BlackRock Advisors first reported a position in NTUS in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.78M in Q1 2016. 237 funds tracked by Wall St. Rank hold NTUS as of Q4 2016.

  • BlackRock Advisors held 17,375 shares of Natus Medical Inc worth $605K as of Q4 2016.
  • BlackRock Advisors bought 120 Natus Medical Inc shares in Q4 2016, an estimated $4.71K.
  • Natus Medical Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2100 holding.
  • BlackRock Advisors first reported a position in Natus Medical Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Natus Medical Inc position peaked at $2.78M in Q1 2016.
  • 237 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.